← Back
$RIGL All transactions

RIGEL PHARMACEUTICALS INC

A

$ Value

$0

Shares

7,394

Price

$0

Filed

Sep 17

Insider

Name

Schorno Dean L

Title

EVP & Chief Financial Officer

CIK

0001509688

Roles

Officer

Transaction Details

Transaction Date

2025-09-15

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

7,394

Footnotes

The Reporting Person was granted a stock option with a performance-based condition with respect to 7,394 shares of the Issuer's common stock on January 29, 2025. The exercise price of this option is $22.49, which is the closing price of the Issuer's common stock on Nasdaq on the date of grant. In light of the performance-based vesting condition, this grant was not reportable under Section 16 until the performance metric was satisfied. On September 15, 2025, it was determined that the performance metric had been met. | The option was fully vested on September 15, 2025, the date the determination was made that the performance metric had been met.

Filing Info

Accession No.

0000905148-25-003351

Form Type

4

Issuer CIK

0001034842

Schorno Dean L's History

Date Ticker Type Value
2026-02-17 RIGL A $0
2026-02-10 RIGL F $123K
2026-02-02 RIGL F $198K
2025-12-22 RIGL M $40K
2025-12-22 RIGL M $69K
2025-12-22 RIGL M $31K
2025-12-22 RIGL M $0
2025-12-22 RIGL M $0
2025-12-22 RIGL M $0
2025-09-15 RIGL A $0

Other Insiders at RIGL (90d)

Insider Bought Sold Last
MOOS WALTER H $145K 2026-02-20
RODRIGUEZ RAUL R
CEO, President
2026-02-17
MILLER MICHAEL PATRICK 2026-02-01
Schorno Dean L
EVP & Chief Financial Officer
2026-02-17
Furey Raymond J.
EVP, GC, CCO & Corp Sec
2026-02-17
Santos David A
EVP, Chief Commercial Officer
2026-02-17
Rojkjaer Lisa
EVP, Chief Medical Officer
2026-02-17